High Concentration Cannabinoid Topical Regimen for Dermatitis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current topical cannabinoid creams for inflammatory skin conditions provide low doses of active agents, which are insufficient to effectively treat dermatitis and other inflammatory skin issues.
Innovation Solution
A topical regimen involving a composition of between 50 mg and 3000 mg of cannabinoids, ranging from 1% to 15% w/w, administered 1 to 5 times daily to deliver 20 mg to 400 mg per application, targeting the skin to reduce inflammation and alleviate symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional topical cannabinoid creams are used, then the skin can be treated with cannabinoids, but the dose of active agent is insufficient to effectively treat dermatitis and inflammatory skin conditions
Solution Approach 1:
The patent fundamentally changes the concentration parameter of cannabinoids in topical creams, increasing from conventional low doses to high doses of 1-15% w/w. This parameter change transforms the product from ineffective to therapeutically effective, directly resolving the contradiction between dose quantity and treatment effectiveness.
Solution Approach 2:
The patent applies excessive action by providing doses of cannabinoids that far exceed conventional amounts. The high concentration formulation (1-15% w/w) delivers sufficient active agent to penetrate skin and achieve therapeutic effects, moving beyond the partial effectiveness of conventional low-dose formulations.
2Reliability
If high concentration of cannabinoids is used, then therapeutic effectiveness is improved, but the composition becomes more potent and requires careful dosing control
Solution Approach 1:
The patent introduces dynamic dosing flexibility by allowing variable application frequencies (1-5 times daily) and adjustable amounts (50-3000 mg per application). This dynamic approach enables users to optimize treatment based on individual needs while maintaining safety, managing the complexity through structured variability rather than fixed rigid protocols.
Solution Approach 2:
The patent segments the dosing strategy into multiple application opportunities throughout the day rather than requiring a single large dose. By dividing the total daily dose into multiple applications, the patent manages the complexity of high-concentration formulations through distributed dosing, improving both safety and compliance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The high concentration of cannabinoids penetrates the skin, effectively reducing inflammation, itch, pain, and other symptoms associated with dermatitis and inflammatory skin conditions, offering a more therapeutic and potentially faster healing solution compared to conventional treatments.
Implementation Method 1
The high concentration of cannabinoids penetrates the skin, effectively reducing inflammation, itch, pain, and other symptoms associated with dermatitis and inflammatory skin conditions
Data Source
AI summary
A treatment regime for use in the treatment or prevention of dermatitis and inflammatory skin conditions, said regime comprising the administration of: a) between 50 mg and 3000 mg of a topical liquid or gel composition comprising between 1% w/w and 15% w/w cannabinoid, wherein the cannabinoid is dissolved in the liquid or gel composition.